A novel pharmaceutical process
We have engineered our proprietary manufacturing technology for Viaskin® patch, which is designed to comply with the most stringent pharmaceutical production standards.
This novel pharmaceutical process, fully developed by DBV, uses an electrospray to spray homogeneous, thin, dry protein layers onto the Viaskin® patch.
This process sprays a liquid solution of electrically charged proteins onto the patch’s backing, which is then turned into a dry solid charged particle, which remains stuck onto the patch’s backing. This fully patented technology is highly scalable and complies with cGMP requirements.